Automated, fit-for-purpose tools are essential in CAR-T processing to support sustainable manufacturing of clinical and market-approved cell therapy products. This webinar will discuss how the ekko™ Acoustic Cell Processing System uses acoustic technology as a touchless approach to manipulate cells, enabling a modular tool across the CAR-T manufacturing workflow. Typical performance of templated ekko™ System processes for DMSO washout of leukapheresis material, low volume and high cell concentrate for electroporation preparation, and harvest of expanded T cells will be reviewed. This webinar will also give an early glimpse at the ekko™ Select System for unmatched T cell selection.
In this webinar:
Acoustic Technology Expert
Benjamin Ross-Johnsrud is an acoustic technology expert for cell therapy processing at Merck. As part of his role, Ben leads customer engagement activities, demonstrating the capabilities of our acoustic cell processing technology, the ekko™ System.
He is an expert in conceptualizing new manufacturing paradigms, using the full breadth of acoustics to adapt process requirements to the growing needs of commercial cell therapy supply. Ben is a co-inventor on 17 patents to date, with a drive to expand our company's product offering to power the next generation of cell therapies. Ben has his B.S. in engineering from Western New England University.
Mechanical Engineer III
Robert Scott is a mechanical engineer III in the acoustics processing and engineering Group at Merck.
In his role, Rob is responsible for process and application development, demonstrating the capabilities of our ekko™ Acoustic Cell Processing System for over three years. He initially joined FloDesign Sonics as an intern from Western New England University's engineering program where he received two degrees, an M.S. in engineering management and a B.S. in mechanical engineering.
Pharma and biopharma manufacturing
Session 1:presented June 9, 2022
To continue reading please sign in or create an account.Don't Have An Account?